Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography

Clinical trial NCT04851769 · COMPLETED

Trial details

NCT number: NCT04851769
Sponsor: Beijing Anzhen Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Randomized Controlled Trials

Start date: 2019-03-02
Primary completion: 2021-01-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.